Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Side effects

IDSA: No Race or Gender Safety Issues Observed in Studies (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
24 October 2010
Adherence

IDSA: Experienced Providers May Boost HIV Treatment Adherence (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
24 October 2010
Starting treatment

IDSA: Physicians Lag in Adopting Earlier Tx Initiation (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
23 October 2010
Adherence

IDSA: Cell Phones Improve HIV Care (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
23 October 2010
New & experimental HIV treatments

IDSA: Cancer Gene Plays Key Role in HIV Infection (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
22 October 2010
HIV treatment for children & young people

Fixed dose ARV for children: half-dose to limit nevirapine rash is safe in first 2 weeks

News
22 October 2010
Cardiovascular disease

Drug safety bodies issue warning on heart rhythm risks with saquinavir (Invirase)

News
22 October 2010
Neurological & cognitive problems

Neurotune presents positive dimiracetam Phase IIa results for treatment of neuropathic pain in HIV-positive patients

Editor's pick
Pharmaceutical Business Review
22 October 2010
New & experimental HIV treatments

Shionogi-ViiV Healthcare begin two phase III studies for investigational once-daily HIV integrase inhibitor

Editor's pick
Market Watch
21 October 2010
Bone & joint problems

Switch from efavirenz or AZT associated with improvement in vitamin D levels

News
20 October 2010
Starting treatment

Gilead Profit Beats Forecasts on Jump in HIV Drug Sales

Editor's pick
CNBC
19 October 2010
New & experimental HIV treatments

Cytheris Announces Initiation of ORVACS-Sponsored Phase II Clinical Study to Attack Viral Reservoir of HIV Patients

Editor's pick
Reuters
19 October 2010
Neurological & cognitive problems

NeurogesX to pursue expanded U.S. label for Qutenza® (capsaicin) 8% patch in HIV-associated neuropathy

Editor's pick
PR Newswire
18 October 2010
Cancer

Starting antiretroviral treatment does not reduce the incidence or prevalence of cervical infection with human papillomavirus

News
18 October 2010
Changing treatment

Adding drugs to already successful HIV treatment doesn't reduce viral load further

News
15 October 2010
Changing treatment

Targeted viral load tests in India prevent switches to second-line ARVs for one in four

News
13 October 2010
Adherence

Adherence key to reducing genital HIV levels in women

News
12 October 2010
Improving HIV care

Zimbabwe: Zim Agonisingly Navigates HIV Minefield

Editor's pick
AllAfrica
11 October 2010
Cardiovascular disease

Low CD4 cell count associated with heart attack in patients with HIV

News
7 October 2010
Resistance

New computer modelling system predicts responses to HIV and AIDS treatments

Editor's pick
Science Daily
7 October 2010
Government, leadership & policy

Fighting AIDS: An Oral History

Editor's pick
Slate
7 October 2010
People who inject drugs

Call to change methadone use law

Editor's pick
BBC Health
7 October 2010
Cardiovascular disease

Individual risk factors crucial in determining a patient's risk of heart attack if taking abacavir

News
6 October 2010
Changing treatment

Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR For Generic Version Of Reyataz® Capsules HIV Treatment

Editor's pick
HIV / AIDS News From Medical News Today
6 October 2010